Anti-GABA A receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia.

Competing Interests: Declaration of interests We declare no competing interests relating to the content of the manuscript. ÖY reports honoraria from Biogen. HHH reports grants from Moderna to the University of Basel; and he reports personal consulting fees from AlCuris, Allovir, Moderna, VeraTX, and Roche, and personal honoraria from VeraTX, Takeda, Biotest, and Gilead. UFischer reports research grants from the Swiss National Science Foundation, the Swiss Heart Foundation, Medtronic, Stryker, Penumbra, Rapid medical, Phenox, and Boehringer Ingelheim; consulting fees from Medtronic, Stryker, CSL Behring (fees paid to institution); has membership in a data safety monitoring board for the TITAN trial, IN EXTREMIS trial, LATE-MT trial, Rapid Puls Trial; has membership in the Clinical Event Committee of the COATING Trial (Phenox) and membership in the advisory board for CLS Behring, Acthera, Alexion/Portola, Boehringer Ingelheim (all fees paid to institution); is president of the Swiss Neurological Society.